Article Information
History
- December 30, 2019.
Article Versions
- You are currently viewing Version 1 of this article (December 30, 2019 - 13:14).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Shunsuke Kataoka1,2,
- Priyanka Manandhar1,3,
- Creg J. Workman1,
- Hridesh Banerjee1,
- Andrea L. Szymczak-Workman1,
- Michael Kvorjak4,
- Jason Lohmueller4 and
- Lawrence P. Kane1,*
- 1Department of Immunology, University of Pittsburgh, Pittsburgh, PA 15261
- 2Asahi-Kasei Pharma Corporation, Shizuoka, Japan
- 3Graduate Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, PA 15261
- 4Department of Surgery, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15261
- ↵*To whom correspondence should be addressed; lkane{at}pitt.edu